Stay updated on Magrolimab vs. Venetoclax in TP53 AML Clinical Trial

Sign up to get notified when there's something new on the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.1 to v3.6.3, indicating a refreshed publication of the page. This change does not modify study details or outcomes; it serves as a metadata version update.
    Difference
    0.0%
    Check dated 2026-07-02T14:35:47.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.1, replacing Revision: v3.6.0. This reflects a release update to the page's version metadata and does not indicate changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-25T10:56:44.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now includes new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and displays the recruitment update 'No longer looking for participants', while the 'Intervention / Treatment' label has been updated to 'Intervention/Treatment' and the revision version updated to v3.6.0, reflecting a mix of usability improvements and formatting/documentation updates.
    Difference
    0.2%
    Check dated 2026-06-11T04:12:48.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added the revision tag 'Revision: v3.5.5' and removed 'Revision: v3.5.4', signaling a minor update to the page's revision metadata.
    Difference
    0.0%
    Check dated 2026-06-02T22:44:25.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A new document revision, Revision: v3.5.4, was added to the study record, replacing Revision: v3.5.3. This update indicates an updated version of the study protocol and related documentation.
    Difference
    0.0%
    Check dated 2026-05-19T12:31:01.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.5.3 was added and Revision: v3.5.2 was removed. This indicates a minor version update to the page rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-04-27T19:54:21.000Z thumbnail image

Stay in the know with updates to Magrolimab vs. Venetoclax in TP53 AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page.